First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials
Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment
Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment
Scientists at Scripps Research unveil the effects of microgravity on brain cells. Microgravity is known to affect muscles, bones, the
No posts found.